Patents Assigned to The Salk Institute Biotechnology/Industrial Assoc, Inc.
  • Patent number: 5429921
    Abstract: Human calcium channel .alpha..sub.1 -, .alpha..sub.2 -, .beta.- and .gamma.-subunit encoding cDNAs, and related compositions and methods, are provided.
    Type: Grant
    Filed: August 15, 1991
    Date of Patent: July 4, 1995
    Assignee: The Salk Institute Biotechnology/Industrial Assoc. Inc.
    Inventors: Michael M. Harpold, Steven B. Ellis, Mark E. Williams, Daniel H. Feldman, Ann F. McCue, Robert Brenner
  • Patent number: 5324660
    Abstract: The isolation and characterization of genes involved in proteolytic processing in species of the genus Pichia is described. The availability of such genes has enabled the generation of strains of Pichia which are deficient in proteolytic activity, which strains are useful as hosts for the expression of proteolytically sensitive recombinant products. The isolation and characterization of additional genes from species of the genus Pichia is also described, as well as uses therefore.
    Type: Grant
    Filed: July 6, 1993
    Date of Patent: June 28, 1994
    Assignee: The Salk Institute Biotechnology/Industrial Assoc. Inc.
    Inventors: Martin A. Gleeson, Bradley D. Howard
  • Patent number: 5324639
    Abstract: Insulin-like growth factor-1 (IGF-1), a naturally occurring, relatively short, single chain polypeptide, is prepared by growing methylotrophic yeast transformants containing in their genome at least one copy of a DNA sequence operably encoding IGF-1, in operational association with a DNA sequence encoding the S. cerevisiae alpha mating factor pre-pro sequence (including the proteolytic processing site: lys-arg), both under the regulation of a promoter region of a gene of a methylotrophic yeast, under conditions allowing expression of said DNA sequences, and secretion of IGF-1 into the culture medium.Also disclosed are novel DNA fragments and novel recombinant yeast strains which are useful in the practice of the present invention.
    Type: Grant
    Filed: February 25, 1993
    Date of Patent: June 28, 1994
    Assignee: The Salk Institute Biotechnology/Industrial Assoc, Inc.
    Inventors: Russell A. Brierley, Geneva R. Davis, Gregory C. Holtz